Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 4;48(12):0300060520959502. doi: 10.1177/0300060520959502

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Cardiac ultrasound indices before and after treatment in STEMI patients. The control group (n = 44) and observation group (n = 40) were given oral atorvastatin (80 mg before thrombolytic therapy and subsequent doses of 20 mg/day for 2 months) or a combination of atorvastatin and ticagrelor (initial dose of 180 mg and subsequent doses of 90 mg two times per day for 2 months), respectively. (A) Both groups demonstrated a decrease in LVESD, which was significant in the observation group. (B) Both groups demonstrated a decrease in LVEDD, which was significant in the observation group. (C) Both groups demonstrated an increase in LVEF, which was significant in the observation group. The results are presented as the mean ± standard deviation, and * represents p < 0.05.

ST-segment elevation myocardial infarction, STEMI; LVESD, left ventricular end-diastolic diameter; LVEDD, left ventricular end-systolic diameter; LVEF, left ventricular ejection fraction.